Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

The prevalence of serious inflammatory safety issues such as cytokine release syndrome and immune effector cell–associated ...

Advancing valuable commercial opportunity in stiff person syndrome (SPS) following landmark registrational data; Biologics ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the importance of long-term monitoring. A recent study reveals CAR T-cell therapy ...

One patient still in remission 3 years after single infusion of base-edited CAR7 T cells ...

GM is stepping away from hydrogen, while Honda will get by without any help from its friends.

However, hydrogen hasn’t yet caught on as a large-scale solution largely due to funding, even though even the US Department ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Volvo has slightly scaled back its once ambitious electric plans, but the Swedish automaker already offers a wide range of ...

An American citizen said ICE agents smashed his car windows and jailed him for eight hours for monitoring their ...